SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2193275

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2193275

Absorbable Surgical Sutures Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Absorbable Surgical Sutures Market reached USD 3.05 billion in 2025 and is projected to grow at a 6.5% CAGR from 2026 to 2035. The market is expected to cross USD 5.68 billion valuation by 2035. Natural and synthetic materials provide degradable wound-closure options in single-strand and braided forms. Procedure growth creates recurring consumption, while care-site migration and newer configurations influence procurement. Hospitals and outpatient facilities increasingly assess handling, predictable absorption, antimicrobial properties, and knotless functionality within their formulary and operating requirements.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$3.05 Billion
Forecast Value$5.68 Billion
CAGR6.5%

Expanding surgical access supports the supply chains needed before new operating capacity can increase throughput. Developing health systems increasingly move toward synthetic materials with consistent tensile retention and absorption behavior. These changes affect several surgical specialties rather than one elective category. Ambulatory migration creates a separate procurement channel through standardized kits, manageable stock, and efficient handling. Medical directors and outpatient supply teams influence choices outside conventional hospital contracts. Antimicrobial and knotless products add another differentiation mechanism through infection-sensitive protocols and operating-room workflow. Adoption depends on evidence, familiarity, and approvals across relevant configurations. Commercial opportunity therefore combines additional procedures with changes in where and how products are selected, requiring suppliers to address clinical handling and channel-specific support alongside dependable material supply.

Based on material, natural sutures generated USD 244 million in 2025. Plain and chromic gut retain applications where rapid absorption, surgeon experience, or purchasing affordability influence choice. Established use provides continuing demand in selected settings. Hospitals increasingly favor synthetics where predictable retention and absorption and lower tissue reactivity matter. Commercial positioning therefore depends on the specific procedure and procurement environment rather than broad substitution across all closure uses. Suppliers serving natural-material requirements need dependable quality and access to the relevant accounts. The segment retains a role where its characteristics and economics fit routine needs, while changing clinical preferences narrow opportunities in settings adopting more consistent synthetic alternatives.

By structure, monofilament sutures are projected to generate USD 3.11 billion by 2035. Smooth tissue passage, reduced capillary behavior, and compatibility with barbed designs support use. Infection-sensitive and ambulatory workflows place particular emphasis on predictable handling with fewer operating steps. Commercial demand consequently reflects procedural requirements alongside the material itself. Suppliers must provide suitable configurations and support the clinical familiarity needed for formulary use. The segment connects closure performance with workflow priorities, allowing clinicians to assess how the strand and device format fit the procedure. Adoption therefore depends on the practical benefits recognized in actual use and the purchasing channels through which hospitals and outpatient facilities select qualified products.

The North America absorbable surgical sutures market is projected to generate USD 1.76 billion by 2035. Extensive surgical infrastructure and established formularies provide recurring demand. Developed ambulatory networks create additional purchasing routes. Mature procedure volumes place greater emphasis on product upgrades than on simple expansion alone. Antimicrobial, knotless, and specialized monofilament formats gain relevance where clinical protocols and workflow support adoption. Commercial opportunity therefore includes differentiated products within familiar accounts. Suppliers need evidence, surgeon support, and appropriate contracts across hospital and outpatient settings, connecting dependable closure materials with the service and availability required to retain formulary positions in an established surgical environment.

Johnson and Johnson (Ethicon) held over 36.0% market share in 2025. Vicryl, PDS, Monocryl, and STRATAFIX provide a broad closure portfolio. Longstanding clinical relationships support access across hospital and ambulatory accounts. Continued approvals for antimicrobial and knotless configurations reinforce development beyond basic price competition. Customers assess handling and protocol fit alongside the available range. Ethicon's commercial position connects familiar franchises with newer devices that can address procedure requirements. Its resources support formulary retention where physicians value established use and buyers need dependable supply. The breadth of the portfolio allows participation across different closure needs while maintaining opportunities to introduce differentiated formats through existing clinical and purchasing relationships.

Some of the major players in this market are B. Braun (Aesculap), Medtronic, Corza Medical, CONMED, Advanced Medical Solutions, Peters Surgical, Demetech, Futura Surgicare, Genesis MedTech, Healthium Medtech, Integra Lifesciences, Lotus Surgicals, Unisur, Vital Sutures, and Vitrex Medical Group. Specialty procedures, wound-closure expertise, regional manufacturing, and value-oriented distribution create different positions. Ophthalmic and neurosurgical relationships support focused suppliers, while broader portfolios address consolidated purchasing. Regulatory access, consistent quality, affordability, and dependable supply influence competition across premium institutions and routine public-sector procurement.

Product Code: 14562

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Scope and Definition
  • 1.2 Research Design
    • 1.2.1 Research Approach
    • 1.2.2 Data Collection Methods
  • 1.3 Data Mining Sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base Estimates and Calculations
    • 1.4.1 Base Year Calculation
    • 1.4.2 Key Trends for Market Estimation
  • 1.5 Primary Research and Validation
    • 1.5.1 Primary Sources
  • 1.6 Forecast Model
  • 1.7 Research Assumptions and Limitations

Chapter 2. Executive Summary

  • 2.1 Industry 360° Synopsis
  • 2.2 Key Market Trends
    • 2.2.1 Regional Trends
    • 2.2.2 Material Trends
    • 2.2.3 Structure Trends
    • 2.2.4 Application Trends
    • 2.2.5 End Use Trends
  • 2.3 CXO Perspectives: Strategic Imperatives
    • 2.3.1 Key Decision Points for Industry Executives
    • 2.3.2 Critical Success Factors for Market Players
  • 2.4 Future Outlook and Strategic Recommendations

Chapter 3. Industry Insights

  • 3.1 Industry Ecosystem Analysis
  • 3.2 Industry Impact Forces
    • 3.2.1 Growth Drivers
      • 3.2.1.1 Increasing Prevalence of Chronic Diseases
      • 3.2.1.2 Rising Surgical Procedures Worldwide
      • 3.2.1.3 Advancements in Suture Materials
      • 3.2.1.4 Increasing Number of Gynecological Procedures
    • 3.2.2 Industry Pitfalls and Challenges
      • 3.2.2.1 High Cost of Procedures
      • 3.2.2.2 Stringent Regulatory Framework
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Growing Demand for Minimally Invasive Surgeries
  • 3.3 Growth Potential Analysis
  • 3.4 Regulatory Landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technological Advancements
    • 3.5.1 Current Technological Trends
    • 3.5.2 Emerging Technologies
  • 3.6 Supply Chain Analysis
  • 3.7 Future Market Trends
  • 3.8 Gap Analysis
  • 3.9 Porter's Analysis
  • 3.10 PESTEL Analysis

Chapter 4. Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company Market Share Analysis
  • 4.3 Company Matrix Analysis
  • 4.4 Competitive Analysis of Major Market Players
  • 4.5 Competitive Positioning Matrix
  • 4.6 Key Developments
    • 4.6.1 Mergers and Acquisitions
    • 4.6.2 Partnerships and Collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5. Market Estimates and Forecast, By Material, 2022 - 2035 ($ Mn)

  • 5.1 Key Trends
  • 5.2 Natural Suture
  • 5.3 Synthetic Suture
    • 5.3.1 Vicryl
    • 5.3.2 Polydioxanone Suture (PDS)
    • 5.3.3 Poliglecaprone Suture (Monocryl)

Chapter 6. Market Estimates and Forecast, By Structure, 2022 - 2035 ($ Mn)

  • 6.1 Key Trends
  • 6.2 Monofilament
  • 6.3 Multifilament

Chapter 7. Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 7.1 Key Trends
  • 7.2 Cardiovascular Surgery
  • 7.3 Gynaecology Surgery
  • 7.4 Orthopaedic Surgery
  • 7.5 Ophthalmic Surgery
  • 7.6 Neurological Surgery
  • 7.7 Other Surgical Applications

Chapter 8. Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 8.1 Key Trends
  • 8.2 Hospitals
  • 8.3 Specialty Clinics
  • 8.4 Ambulatory Surgical Centres
  • 8.5 Other End Use

Chapter 9. Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 9.1 Key Trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE

Chapter 10. Company Profiles

  • 10.1 Advanced Medical Solutions
  • 10.2 B. Braun
  • 10.3 Corza Medical
  • 10.4 CONMED
  • 10.5 Demetech
  • 10.6 Futura Surgicare
  • 10.7 Genesis MedTech
  • 10.8 Healthium Medtech
  • 10.9 Integra Lifesciences
  • 10.10 Johnson & Johnson
  • 10.11 Medtronic
  • 10.12 Lotus Surgicals
  • 10.13 Unisur
  • 10.14 Vital Sutures
  • 10.15 Vitrex Medical Group
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!